SlideShare a Scribd company logo
1 of 28
Under the guidance of
Ms. Srujani M.Pharm., (PhD).
Submitted by
S. Srilakshmi
M.Pharm. 1st Year
y14mph328
Department Of Pharmaceuticals Analysis
ACHARYA NAGARJUNA UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES
GOOD LABORATORY PRACTICES
INTRODUCTION TO GLP
Definition:
GLP may be defined as a body rules, operating
procedures, and practices established by a given
organization, that are considered to be mandatory with a
view to ensuring quality and correctness in the results
produced by a laboratory.
OR
GLP is a quality system concerned with the
organizational process and conditions under which non-
clinical health and environmental safety studies are
planned, performed, monitored, recorded, archived and
reported.
HISTORY OF GLP
 GLP was first introduced in New Zealand and
Denmark in 1972, and later in the US in 1978 in
response to the ”Industrial BioTest Labs” scandal.
 It was followed a few years later by the
Organization for Economic Co-operation and
Development (OECD) Principles of GLP in 1992;
the OECD has since helped promulgate GLP to many
countries.
ELEMENTS OF GLP
STANDARD OPERATING PROCEDURE (SOP)
Usually provide an elaborated description of various on-
going activities carried out Analytical laboratory.
Examples:
Sample handling and preparation
Analytical method used
Proper maintenance of all instruments
Record keeping.
QUALITY ASSURANCE UNIT (QAU)
QAU is entirely responsible for assuring GLP being
implemented effectively.
The prime responsibilities that are exclusively fall within
the domain of QAU are -
oImplementation of quality procedures.
oAssessment of quality procedures on a continual basis.
oAudits of the laboratory periodically.
OBJECTIVES OF GLP
 Adopt good and safe operating procedures and
recording systems.
 Prevent human errors in the performance of the
job.
 Prevent equipment errors in measurements.
 Prevent unsafe and hazardous acts which could
affect individuals and/or properly.
 Improve efficient performance of the job.
THE IDEA BEHIND GLP
It belongs to the functions of the respective
authorities to make sure that the safety and the
environment is proven safety claims can be verified.
 A regulatory authority may then obtain verification of
such an experimental result by either two ways.
1. It self
2. Step-by-step
CONTINUE…
The GLP principles are designed as a tool
enabling also the improvement of study and data
quality .
All these requirements can be summarized in three
issues that are central to the ideas behind GLP.
Possibility
Accountability
GLP increases awareness.
CONTINUE…
1. POSSIBILITY:
To reconstruct the whole course of a safety study, even years
after it has been performed and even in the absence of
persons having been actively involved in the conduct of this
specific study.
Ex: All the animals have received the correct dose of the test
item at all times, that the correct samples have been taken and
analyzed, and the actual data that had been collected.
These report submitted to the Regulatory Authority.
CONTINUE…
2.ACCOUNTABILITY
It is very closely connected with the first one. The
documentation needed in the GLP compliant conduct of a
study will tell years later who was doing what, and who
could be held accountable for mistakes.
3.GLP INCREASE AWARENESS
It awareness of management for the never ending task to
strive for optimal quality and transparency of the studies
conducted at their test facilities of study directors for the
orderly performance of the studies they are to control.
SCOPE OF GLP
 The scope of GLP as it is defined in the OECD Principles,
and which states that GLP encompasses:
“the non-clinical safety testing of test items contained in
pharmaceutical products, pesticide products, cosmetic products,
veterinary drugs as well as food additives, feed additives, and
industrial chemicals. These test items are frequently synthetic
chemicals, but may be of natural or biological origin and, in
some circumstances, may be living organisms.
 The purpose of testing these test items is to obtain data on
their properties and/or their safety with respect to human
health and/or the environment.” (OECD, 1998).
THE AREAS OF APPLICATION
 GLP is applicable to safety studies in two major areas:
1. Effects on human health
2. Effects on the environment
 These two areas may share some types of studies that
have to be conducted in order to test the safety of the
respective test item, but other study types may exclusively
be required for one or the other area.
 The second point to be observed in the judgment on the
necessity for GLP adherence is that these studies are not
only conducted to “obtain data on properties and/or its
safety”, but that they are “intended for submission to
appropriate regulatory authorities”.
CONTINUE…
The applicability of GLP to “human health and environmental
safety” testing spells out yet another facet of this delimitation which
may give rise to a number of questions. Laboratory testing that is
performed in a non safety-related way.
Example:
The physical-chemical parameters of a pharmaceutical chemical
substance might thus not be considered as related to an assessment
of human health risks. For a pesticide or another environmental
substance, however, parameters like their vapour pressure, their
acid-base equilibrium constant or their water/octanol partition
coefficient, all of which will determine the nature and extent of
environmental dissipation, and accumulation, will certainly be
safety-related data that have to be generated under GLP.
CONTINUE…
 The data to be generated under GLP have to have a connection
to the assessment of safety for either of the two fields of
human health or for the environment. In this regard there
are apparent differences between these two fields.
 The necessity to follow the strict regulations of GLP will be
determined by the two basic principles of the scope of GLP –
the safety-relatedness of the investigation and the
foreseeable submission to an Regulatory Authority – the
interpretation of which may, however, under different
circumstances lead to different answers and conclusions.
THE PILLARS OF GOOD LABORATORY PRACTICES
Good Laboratory Practice is based on four pillars
which have to support the implementation and daily
observance of its Principles:
The Management
The Quality Assurance
The Study Director
The National Compliance Monitoring Authority
THE MANAGEMENT
 A management which is convinced that GLP is a
good thing in itself.
 Therefore, an essential management responsibility is
the appointment and effective organization of an
adequate number of appropriately qualified and
experienced staff throughout the facility, including
those specifically required to perform QA functions.
 And this management responsibility brings us to the
second pillar of Good Laboratory Practice.
THE QUALITY ASSURANCE
The second pillar of this building, named GLP, is the Quality
Assurance, an internal system for ensuring that the Principles of
GLP are observed.
 The compliance with the GLP standards in the everyday work
at a test facility can only be as good as the critical
observational capability of the Quality Assurance inspector
on the one hand, and also only as good as the ability of the
Quality Assurance manager to succeed in carrying through
any objections to the way GLP is handled by individual
persons.
 Quality Assurance may thus be regarded as the prolonged arm
of management, which exercises its control over the GLP
compliance within the test facility.
THE STUDY DIRECTOR
The third pillar of the GLP system consists of
one single person! The Study Director is the one
single point of study control and the one single
person on whom the whole study hinges from the
beginning to the end.
The Study Director is usually the scientist
responsible for study plan design and approval,
as well as for overseeing data collection, analysis
and reporting, and for drawing the final overall
conclusions from the study.
NATIONAL COMPLIANCE MONITORING AUTHORITY
 It is the National Compliance Monitoring Authority for the
international recognition and mutual acceptance of studies and
test data.
 This Recommendation sets out the basic characteristics of the
procedures for monitoring compliance with the GLP
Principles, and following this Recommendation two guidance
documents on “Compliance Monitoring Procedures for
GLP” and on the “Conduct of Laboratory Inspections and
Study Audits”, both directed at the National Monitoring
Authorities, were issued.
 This fourth pillar of GLP is the comparability of the
monitoring procedures, mutual trust is achieved and the
mutual acceptance of safety test data will be possible.
WHERE CAN GLP BE PROFITABLY APPLIED…?
 The term “Good Laboratory Practice” is restricted to
apply to such test facilities only, which are performing
“human health and environmental safety studies”, studies
which furthermore have to be submitted to a Regulatory
Agency for assessment. It is evident that not every
laboratory would fulfil these conditions.
 Outside the field of “non-clinical human health and
environmental safety” testing, where GLP has to apply,
official recognition should be based on quality standards
other than GLP, since GLP is absolutely confined to the
said area.
PRINCIPLES OF GLP
The important principles are not new, nor are they unknown; they
can be summarized as follows:
 There should be a unique identification for the study and all of its
parts.
 All original observations in a study should be immediately, clearly
and legibly recorded.
 All records should be in the form of bound notebooks or on
continuously numbered sheets.
 All entries and corrections to them should be dated and initialed.
 Records related to the test system itself should be gathered and
retained.
 Specimens should be clearly identified so as to allow full
traceability.
 At the end of a study, all raw data should be assembled, catalogued
and archived.
CONTINUE…
The GLP Principles are much more demanding in
this respect, and in the section on the “Conduct of
the Study”, the following instructions are given for
the recording of data:
 All data generated during the conduct of the
study should be recorded directly, promptly,
accurately, and legibly by the individual entering
the data. These entries should be signed or initialed
and dated.
CONTINUE…
 The possibilities inherent in the applicable
control mechanisms might subsequently provide
the means for judging the shortcomings of the
present activities and for improving the scientific
quality of the future work.
REFERENCES
 Good Laboratory Practice – the Why and
the How by Jürg P. Seiler
THANK
YOU....

More Related Content

What's hot

Glp 112070804004
Glp  112070804004Glp  112070804004
Glp 112070804004Patel Parth
 
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTIONPHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTIONPrincy Agarwal
 
Pharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul DalviPharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul DalviRahul Dalvi
 
Quality Assurance and Quality Management Concepts
Quality Assurance and Quality Management ConceptsQuality Assurance and Quality Management Concepts
Quality Assurance and Quality Management ConceptsVivek Jain
 
BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)Ram Mohan S R
 
INTRODUCTION TO QUALITY BY DESIGN (QBD)
INTRODUCTION TO QUALITY BY DESIGN (QBD)INTRODUCTION TO QUALITY BY DESIGN (QBD)
INTRODUCTION TO QUALITY BY DESIGN (QBD)Chetan Pawar 2829
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validationSUBHASISH DAS
 
Out of specification shravan
Out of specification shravanOut of specification shravan
Out of specification shravanshravan dubey
 
NABL ACCREDITATION
NABL ACCREDITATIONNABL ACCREDITATION
NABL ACCREDITATIONTeny Thomas
 
USFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratoriesUSFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratoriesswrk
 
good laboratory practices
good laboratory practicesgood laboratory practices
good laboratory practicesrasika walunj
 
Qualification of UV VISIBLE SPECTROPHOTOMETER
Qualification of UV VISIBLE SPECTROPHOTOMETERQualification of UV VISIBLE SPECTROPHOTOMETER
Qualification of UV VISIBLE SPECTROPHOTOMETERDr.K.Venkateswara raju
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validationGaurav Kr
 
Pharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualificationsPharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualificationsSuraj Ghorpade
 

What's hot (20)

Ich guidelines
Ich guidelinesIch guidelines
Ich guidelines
 
Glp 112070804004
Glp  112070804004Glp  112070804004
Glp 112070804004
 
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTIONPHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
 
ICH AND ICH GUIDELINES
ICH AND ICH GUIDELINESICH AND ICH GUIDELINES
ICH AND ICH GUIDELINES
 
Pharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul DalviPharmaceutical validation ppt Rahul Dalvi
Pharmaceutical validation ppt Rahul Dalvi
 
Quality Assurance and Quality Management Concepts
Quality Assurance and Quality Management ConceptsQuality Assurance and Quality Management Concepts
Quality Assurance and Quality Management Concepts
 
BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)
 
INTRODUCTION TO QUALITY BY DESIGN (QBD)
INTRODUCTION TO QUALITY BY DESIGN (QBD)INTRODUCTION TO QUALITY BY DESIGN (QBD)
INTRODUCTION TO QUALITY BY DESIGN (QBD)
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Quality by design (qbd)
Quality by design (qbd)Quality by design (qbd)
Quality by design (qbd)
 
Out of specification shravan
Out of specification shravanOut of specification shravan
Out of specification shravan
 
NABL ACCREDITATION
NABL ACCREDITATIONNABL ACCREDITATION
NABL ACCREDITATION
 
Process validation
Process validationProcess validation
Process validation
 
USFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratoriesUSFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratories
 
good laboratory practices
good laboratory practicesgood laboratory practices
good laboratory practices
 
Qualification of UV VISIBLE SPECTROPHOTOMETER
Qualification of UV VISIBLE SPECTROPHOTOMETERQualification of UV VISIBLE SPECTROPHOTOMETER
Qualification of UV VISIBLE SPECTROPHOTOMETER
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Good Manufacturing Practices for Pharmaceuticals
Good Manufacturing Practices for PharmaceuticalsGood Manufacturing Practices for Pharmaceuticals
Good Manufacturing Practices for Pharmaceuticals
 
personnel,training,hygeine
personnel,training,hygeine personnel,training,hygeine
personnel,training,hygeine
 
Pharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualificationsPharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualifications
 

Viewers also liked

Case control study – part 1
Case control study – part 1Case control study – part 1
Case control study – part 1Rizwan S A
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringNaser Tadvi
 
Case control & other study designs-i-dr.wah
Case control & other study designs-i-dr.wahCase control & other study designs-i-dr.wah
Case control & other study designs-i-dr.wahMmedsc Hahm
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial designUrmila Aswar
 
Good Clinical Practices
Good Clinical PracticesGood Clinical Practices
Good Clinical PracticesKarun Kumar
 
Effective clinical trial design
Effective clinical trial designEffective clinical trial design
Effective clinical trial designidkpharma
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial designSandhya Talla
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory PracticesSwapnil Fernandes
 
Good Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilGood Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilSwapnil Patil
 
Good Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality ControlGood Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality ControlDr Rajendra Patel
 
Good Laboratory Practice Documentation
Good Laboratory Practice DocumentationGood Laboratory Practice Documentation
Good Laboratory Practice DocumentationSunando Basu
 
Antibiotics requiring therapeutic drug monitoring(1)
Antibiotics requiring therapeutic drug monitoring(1)Antibiotics requiring therapeutic drug monitoring(1)
Antibiotics requiring therapeutic drug monitoring(1)Mahen Kothalawala
 
Drug receptor interactions and types of receptor
Drug receptor interactions and types of receptorDrug receptor interactions and types of receptor
Drug receptor interactions and types of receptorDr. Siddhartha Dutta
 
Good Manufacturing Practice (GMP) 2day course
Good Manufacturing Practice (GMP) 2day course Good Manufacturing Practice (GMP) 2day course
Good Manufacturing Practice (GMP) 2day course Jo Havemann
 

Viewers also liked (20)

Case control study – part 1
Case control study – part 1Case control study – part 1
Case control study – part 1
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Case control & other study designs-i-dr.wah
Case control & other study designs-i-dr.wahCase control & other study designs-i-dr.wah
Case control & other study designs-i-dr.wah
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Good Clinical Practices
Good Clinical PracticesGood Clinical Practices
Good Clinical Practices
 
Animal Handling Program
Animal Handling ProgramAnimal Handling Program
Animal Handling Program
 
Good Laboratory Practices (http://www.ubio.in)
Good Laboratory Practices (http://www.ubio.in)Good Laboratory Practices (http://www.ubio.in)
Good Laboratory Practices (http://www.ubio.in)
 
Case control study
Case control studyCase control study
Case control study
 
Effective clinical trial design
Effective clinical trial designEffective clinical trial design
Effective clinical trial design
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory Practices
 
Good Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilGood Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patil
 
Good Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality ControlGood Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality Control
 
Good Laboratory Practice Documentation
Good Laboratory Practice DocumentationGood Laboratory Practice Documentation
Good Laboratory Practice Documentation
 
Antibiotics requiring therapeutic drug monitoring(1)
Antibiotics requiring therapeutic drug monitoring(1)Antibiotics requiring therapeutic drug monitoring(1)
Antibiotics requiring therapeutic drug monitoring(1)
 
Principle of good clinical practice
Principle of good clinical practicePrinciple of good clinical practice
Principle of good clinical practice
 
Drug receptor interactions and types of receptor
Drug receptor interactions and types of receptorDrug receptor interactions and types of receptor
Drug receptor interactions and types of receptor
 
Good Manufacturing Practice (GMP) 2day course
Good Manufacturing Practice (GMP) 2day course Good Manufacturing Practice (GMP) 2day course
Good Manufacturing Practice (GMP) 2day course
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 

Similar to Good laboratory practices of pharmaceuticals

Similar to Good laboratory practices of pharmaceuticals (20)

Introduction to good laboratory practices
Introduction to good laboratory practicesIntroduction to good laboratory practices
Introduction to good laboratory practices
 
Good laboratory practice
Good laboratory practiceGood laboratory practice
Good laboratory practice
 
Glp
GlpGlp
Glp
 
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptx
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptxGOOD LABORATORY PRACTICE by ILyas Mphil student.pptx
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptx
 
GLP and Schedule 1
GLP and Schedule 1GLP and Schedule 1
GLP and Schedule 1
 
GLP DRA.pptx
GLP DRA.pptxGLP DRA.pptx
GLP DRA.pptx
 
Glp.
Glp.Glp.
Glp.
 
Good laboratory practice
Good laboratory practiceGood laboratory practice
Good laboratory practice
 
WJPR 6039
WJPR 6039 WJPR 6039
WJPR 6039
 
Good Laboratory Practices
Good Laboratory PracticesGood Laboratory Practices
Good Laboratory Practices
 
Glps
GlpsGlps
Glps
 
Glp seminar
Glp  seminarGlp  seminar
Glp seminar
 
Ajeesh glp
Ajeesh glpAjeesh glp
Ajeesh glp
 
good laboratory practices.pptx
good laboratory practices.pptxgood laboratory practices.pptx
good laboratory practices.pptx
 
good laboratory practices.pptx
good laboratory practices.pptxgood laboratory practices.pptx
good laboratory practices.pptx
 
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptxOECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
 
Glp guidelines in_qc_laboratory_as_per_ich
Glp guidelines in_qc_laboratory_as_per_ichGlp guidelines in_qc_laboratory_as_per_ich
Glp guidelines in_qc_laboratory_as_per_ich
 
Good Laboratory Practices.pptx
Good Laboratory Practices.pptxGood Laboratory Practices.pptx
Good Laboratory Practices.pptx
 
Concept of qa, qc, gmp 112070804010
Concept of qa, qc, gmp  112070804010Concept of qa, qc, gmp  112070804010
Concept of qa, qc, gmp 112070804010
 
GUIDELINES TO GLP.pptx
GUIDELINES TO GLP.pptxGUIDELINES TO GLP.pptx
GUIDELINES TO GLP.pptx
 

Recently uploaded

The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024Janet Corral
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 

Recently uploaded (20)

The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 

Good laboratory practices of pharmaceuticals

  • 1. Under the guidance of Ms. Srujani M.Pharm., (PhD). Submitted by S. Srilakshmi M.Pharm. 1st Year y14mph328 Department Of Pharmaceuticals Analysis ACHARYA NAGARJUNA UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES GOOD LABORATORY PRACTICES
  • 2. INTRODUCTION TO GLP Definition: GLP may be defined as a body rules, operating procedures, and practices established by a given organization, that are considered to be mandatory with a view to ensuring quality and correctness in the results produced by a laboratory. OR GLP is a quality system concerned with the organizational process and conditions under which non- clinical health and environmental safety studies are planned, performed, monitored, recorded, archived and reported.
  • 3. HISTORY OF GLP  GLP was first introduced in New Zealand and Denmark in 1972, and later in the US in 1978 in response to the ”Industrial BioTest Labs” scandal.  It was followed a few years later by the Organization for Economic Co-operation and Development (OECD) Principles of GLP in 1992; the OECD has since helped promulgate GLP to many countries.
  • 5. STANDARD OPERATING PROCEDURE (SOP) Usually provide an elaborated description of various on- going activities carried out Analytical laboratory. Examples: Sample handling and preparation Analytical method used Proper maintenance of all instruments Record keeping.
  • 6. QUALITY ASSURANCE UNIT (QAU) QAU is entirely responsible for assuring GLP being implemented effectively. The prime responsibilities that are exclusively fall within the domain of QAU are - oImplementation of quality procedures. oAssessment of quality procedures on a continual basis. oAudits of the laboratory periodically.
  • 7. OBJECTIVES OF GLP  Adopt good and safe operating procedures and recording systems.  Prevent human errors in the performance of the job.  Prevent equipment errors in measurements.  Prevent unsafe and hazardous acts which could affect individuals and/or properly.  Improve efficient performance of the job.
  • 8.
  • 9. THE IDEA BEHIND GLP It belongs to the functions of the respective authorities to make sure that the safety and the environment is proven safety claims can be verified.  A regulatory authority may then obtain verification of such an experimental result by either two ways. 1. It self 2. Step-by-step
  • 10. CONTINUE… The GLP principles are designed as a tool enabling also the improvement of study and data quality . All these requirements can be summarized in three issues that are central to the ideas behind GLP. Possibility Accountability GLP increases awareness.
  • 11. CONTINUE… 1. POSSIBILITY: To reconstruct the whole course of a safety study, even years after it has been performed and even in the absence of persons having been actively involved in the conduct of this specific study. Ex: All the animals have received the correct dose of the test item at all times, that the correct samples have been taken and analyzed, and the actual data that had been collected. These report submitted to the Regulatory Authority.
  • 12. CONTINUE… 2.ACCOUNTABILITY It is very closely connected with the first one. The documentation needed in the GLP compliant conduct of a study will tell years later who was doing what, and who could be held accountable for mistakes. 3.GLP INCREASE AWARENESS It awareness of management for the never ending task to strive for optimal quality and transparency of the studies conducted at their test facilities of study directors for the orderly performance of the studies they are to control.
  • 13. SCOPE OF GLP  The scope of GLP as it is defined in the OECD Principles, and which states that GLP encompasses: “the non-clinical safety testing of test items contained in pharmaceutical products, pesticide products, cosmetic products, veterinary drugs as well as food additives, feed additives, and industrial chemicals. These test items are frequently synthetic chemicals, but may be of natural or biological origin and, in some circumstances, may be living organisms.  The purpose of testing these test items is to obtain data on their properties and/or their safety with respect to human health and/or the environment.” (OECD, 1998).
  • 14. THE AREAS OF APPLICATION  GLP is applicable to safety studies in two major areas: 1. Effects on human health 2. Effects on the environment  These two areas may share some types of studies that have to be conducted in order to test the safety of the respective test item, but other study types may exclusively be required for one or the other area.  The second point to be observed in the judgment on the necessity for GLP adherence is that these studies are not only conducted to “obtain data on properties and/or its safety”, but that they are “intended for submission to appropriate regulatory authorities”.
  • 15. CONTINUE… The applicability of GLP to “human health and environmental safety” testing spells out yet another facet of this delimitation which may give rise to a number of questions. Laboratory testing that is performed in a non safety-related way. Example: The physical-chemical parameters of a pharmaceutical chemical substance might thus not be considered as related to an assessment of human health risks. For a pesticide or another environmental substance, however, parameters like their vapour pressure, their acid-base equilibrium constant or their water/octanol partition coefficient, all of which will determine the nature and extent of environmental dissipation, and accumulation, will certainly be safety-related data that have to be generated under GLP.
  • 16. CONTINUE…  The data to be generated under GLP have to have a connection to the assessment of safety for either of the two fields of human health or for the environment. In this regard there are apparent differences between these two fields.  The necessity to follow the strict regulations of GLP will be determined by the two basic principles of the scope of GLP – the safety-relatedness of the investigation and the foreseeable submission to an Regulatory Authority – the interpretation of which may, however, under different circumstances lead to different answers and conclusions.
  • 17. THE PILLARS OF GOOD LABORATORY PRACTICES Good Laboratory Practice is based on four pillars which have to support the implementation and daily observance of its Principles: The Management The Quality Assurance The Study Director The National Compliance Monitoring Authority
  • 18. THE MANAGEMENT  A management which is convinced that GLP is a good thing in itself.  Therefore, an essential management responsibility is the appointment and effective organization of an adequate number of appropriately qualified and experienced staff throughout the facility, including those specifically required to perform QA functions.  And this management responsibility brings us to the second pillar of Good Laboratory Practice.
  • 19. THE QUALITY ASSURANCE The second pillar of this building, named GLP, is the Quality Assurance, an internal system for ensuring that the Principles of GLP are observed.  The compliance with the GLP standards in the everyday work at a test facility can only be as good as the critical observational capability of the Quality Assurance inspector on the one hand, and also only as good as the ability of the Quality Assurance manager to succeed in carrying through any objections to the way GLP is handled by individual persons.  Quality Assurance may thus be regarded as the prolonged arm of management, which exercises its control over the GLP compliance within the test facility.
  • 20. THE STUDY DIRECTOR The third pillar of the GLP system consists of one single person! The Study Director is the one single point of study control and the one single person on whom the whole study hinges from the beginning to the end. The Study Director is usually the scientist responsible for study plan design and approval, as well as for overseeing data collection, analysis and reporting, and for drawing the final overall conclusions from the study.
  • 21.
  • 22. NATIONAL COMPLIANCE MONITORING AUTHORITY  It is the National Compliance Monitoring Authority for the international recognition and mutual acceptance of studies and test data.  This Recommendation sets out the basic characteristics of the procedures for monitoring compliance with the GLP Principles, and following this Recommendation two guidance documents on “Compliance Monitoring Procedures for GLP” and on the “Conduct of Laboratory Inspections and Study Audits”, both directed at the National Monitoring Authorities, were issued.  This fourth pillar of GLP is the comparability of the monitoring procedures, mutual trust is achieved and the mutual acceptance of safety test data will be possible.
  • 23. WHERE CAN GLP BE PROFITABLY APPLIED…?  The term “Good Laboratory Practice” is restricted to apply to such test facilities only, which are performing “human health and environmental safety studies”, studies which furthermore have to be submitted to a Regulatory Agency for assessment. It is evident that not every laboratory would fulfil these conditions.  Outside the field of “non-clinical human health and environmental safety” testing, where GLP has to apply, official recognition should be based on quality standards other than GLP, since GLP is absolutely confined to the said area.
  • 24. PRINCIPLES OF GLP The important principles are not new, nor are they unknown; they can be summarized as follows:  There should be a unique identification for the study and all of its parts.  All original observations in a study should be immediately, clearly and legibly recorded.  All records should be in the form of bound notebooks or on continuously numbered sheets.  All entries and corrections to them should be dated and initialed.  Records related to the test system itself should be gathered and retained.  Specimens should be clearly identified so as to allow full traceability.  At the end of a study, all raw data should be assembled, catalogued and archived.
  • 25. CONTINUE… The GLP Principles are much more demanding in this respect, and in the section on the “Conduct of the Study”, the following instructions are given for the recording of data:  All data generated during the conduct of the study should be recorded directly, promptly, accurately, and legibly by the individual entering the data. These entries should be signed or initialed and dated.
  • 26. CONTINUE…  The possibilities inherent in the applicable control mechanisms might subsequently provide the means for judging the shortcomings of the present activities and for improving the scientific quality of the future work.
  • 27. REFERENCES  Good Laboratory Practice – the Why and the How by Jürg P. Seiler